The contribution of epigenetics in Sjögren's syndrome

Frontiers in Genetics

Volumn 5, Issue APR, 2014, Pages

  Konsta, Orsia D ^a,b   Thabet, Yosra ^a   Le Dantec, Christelle ^a   Brooks, Wesley H ^c   Tzioufas, Athanasios G ^b   Pers, Jacques Olivier ^a   Renaudineau, Yves ^a,d  

^a Universite de Brest   (France)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

DNA methylation; Epithelial cells; HERV; MicroRNAs; Sj gren's syndrome

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AUTOANTIBODY; HISTONE; HISTONE DEACETYLASE; HISTONE METHYLTRANSFERASE; HYDRALAZINE; INTERLEUKIN 1 RECEPTOR; MICRORNA; MICRORNA 146A; MICRORNA 155; PROCAINAMIDE; RITUXIMAB; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; CHROMATIN; DNA METHYLATION; ENDOGENOUS RETROVIRUS; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; HETEROCHROMATIN; HISTONE MODIFICATION; HUMAN; HYPERTENSION; IMMUNOBLOTTING; LYMPHOMA; NONHUMAN; NUCLEOSOME; REGULATORY T LYMPHOCYTE; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; X CHROMOSOME;

EID: 84898467403     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00071     Document Type: Review

References (77)

1. Alevizos, I., Alexander, S., Turner, R. J., and Illei, G. G. (2011). MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum. 63, 535-544. doi: 10.1002/art.30131
2. Altorok, N., Coit, P., Hughes, T., Koelsch, K. A., Stone, D. U., Rasmussen, A., et al. (2014). Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheum. 66, 731-739. doi: 10.1002/art.38264
3. Alunno, A., Petrillo, M. G., Nocentini, G., Bistoni, O., Bartoloni, E., Caterbi, S., et al. (2013). Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Rheumatology (Oxford) 52, 1387-1396. doi: 10.1093/rheumatology/ket179
4. Baimpa, E., Dahabreh, I. J., Voulgarelis, M., and Moutsopoulos, H. M. (2009). Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88, 284-293. doi: 10.1097/MD.0b013e3181b76ab5
5. Balada, E., Ordi-Ros, J., and Vilardell-Tarres, M. (2009). Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev. Med. Virol. 19, 273-286. doi: 10.1002/rmv.622
6. Bannister, A. J., and Kouzarides, T. (2011). Regulation of chromatin by histone modifications. Cell Res. 21, 381-395. doi: 10.1038/cr.2011.22
7. Belkhir, R., Gestermann, N., Koutero, M., Le Seror, R., Tost, J., Mariette, X., et al. (2013). Upregulation of membrane-bound CD40L on CD4 T cells in women with primary Sjögren's syndrome. Scand. J. Immunol. 79, 37-42. doi: 10.1111/sji.12121
8. Bernstein, E., and Allis, C. D. (2005). RNA meets chromatin. Genes Dev. 19, 1635-1655. doi: 10.1101/gad.1324305
9. Bonisch, C., and Hake, S. B. (2012). Histone H2A variants in nucleosomes and chromatin: more or less stable? Nucleic Acids Res. 40, 10719-10741. doi: 10.1093/nar/gks865
10. Brookes, S. M., Pandolfino, Y. A., Mitchell, T. J., Venables, P. J., Shattles, W. G., Clark, D. A., et al. (1992). The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J. Rheumatol. 31, 735-742. doi: 10.1093/rheumatology/31.11.735
11. Brooks, W. H. (2010). X chromosome inactivation and autoimmunity. Clin. Rev. Allergy Immunol. 39, 20-29. doi: 10.1007/s12016-009-8167-5
12. Brooks, W. H., Le Dantec, C., Pers, J. O., Youinou, P., and Renaudineau, Y. (2010). Epigenetics and autoimmunity. J. Autoimmun. 34, J207-J219. doi: 10.1016/j.jaut.2009.12.006
13. Cannat, A., and Seligmann, M. (1968). Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin. Exp. Immunol. 3, 99-105.
14. Christodoulou, M. I., Kapsogeorgou, E. K., Moutsopoulos, N. M., and Moutsopoulos, H. M. (2008). Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am. J. Pathol. 173, 1389-1396. doi: 10.2353/ajpath.2008.080246
15. Cobb, B. L., Lessard, C. J., Harley, J. B., and Moser, K. L. (2008). Genes and Sjögren's syndrome. Rheum. Dis. Clin. North Am. 34, 847-868, doi: 10.1016/j.rdc.2008.08.003
16. Darwaza, A., Lamey, P. J., and Connell, J. M. (1988). Hydrallazine-induced Sjögren's syndrome. Int. J. Oral Maxillofac. Surg. 17, 92-93. doi: 10.1016/S0901-5027(88)80157-7
17. Delgado-Vega, A. M., Alarcon-Riquelme, M. E., and Kozyrev, S. V. (2010). Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Res. Ther. 12(Suppl. 1):S2. doi: 10.1186/ar2883
18. Devauchelle-Pensec, V., Pennec, Y., Morvan, J., Pers, J. O., Daridon, C., Jousse-Joulin, S., et al. (2007). Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. 57, 310-317. doi: 10.1002/art.22536
19. Dieker, J., and Muller, S. (2010). Epigenetic histone code and autoimmunity. Clin. Rev. Allergy. Immunol. 39, 78-84. doi: 10.1007/s12016-009-8173-7
20. Dieker, J. W., Fransen, J. H., Van Bavel, C. C., Briand, J. P., Jacobs, C. W., Muller, S., et al. (2007). Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 56, 1921-1933. doi: 10.1002/art.22646
21. Dozmorov, M. G., Wren, J. D., and Alarcon-Riquelme, M. E. (2014). Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics 9, 276-285. doi: 10.4161/epi.27021
22. Elliott, D. A., Kim, W. S., Gorissen, S., Halliday, G. M., and Kwok, J. B. (2012). Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease. Mov. Disord. 27, 1004-1011. doi: 10.1002/mds.25005
23. Fali, T., Le Dantec, C., Thabet, Y., Jousse, S., Hanrotel, C., Youinou, P., et al. (2013). DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity doi: 10.3109/08916934.2013.826207 [Epub ahead of print].
24. Gallo, A., Tandon, M., Alevizos, I., and Illei, G. G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679. doi: 10.1371/journal.pone.0030679
25. Garaud, S., Le Dantec, C., Jousse-Joulin, S., Hanrotel-Saliou, C., Saraux, A., Mageed, R. A., et al. (2009). IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 182, 5623-5632. doi: 10.4049/jimmunol.0802412
26. Garry, R. F., Fermin, C. D., Hart, D. J., Alexander, S. S., Donehower, L. A., and Luo-Zhang, H. (1990). Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250, 1127-1129. doi: 10.1126/science.1701273
27. Gestermann, N., Koutero, M., Belkhir, R., Tost, J., Mariette, X., and Miceli-Richard, C. (2012). Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome. Eur. Cytokine Netw. 23, 166-172. doi: 10.1684/ecn.2012.0316
28. Gonzalez, S., Aguilera, S., Alliende, C., Urzua, U., Quest, A. F., Herrera, L., et al. (2011). Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 63, 1106-1115. doi: 10.1002/art.30212
29. Hishikawa, T., Ogasawara, H., Kaneko, H., Shirasawa, T., Matsuura, Y., Sekigawa, I., et al. (1997). Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol. 10, 137-147. doi: 10.1089/vim.1997.10.137
30. Hu, S., Vissink, A., Arellano, M., Roozendaal, C., Zhou, H., Kallenberg, C. G., et al. (2011). Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays. Proteomics 11, 1499-1507. doi: 10.1002/pmic.201000206
31. Huber, L. C., Stanczyk, J., Jungel, A., and Gay, S. (2007). Epigenetics in inflammatory rheumatic diseases. Arthritis Rheum. 56, 3523-3531. doi: 10.1002/art.22948
32. Kapsogeorgou, E. K., Gourzi, V. C., Manoussakis, M. N., Moutsopoulos, H. M., and Tzioufas, A. G. (2011). Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J. Autoimmun. 37, 129-135. doi: 10.1016/j.jaut.2011.05.003
33. Konttinen, Y. T., Stegaev, V., Mackiewicz, Z., Porola, P., Hanninen, A., and Szodoray, P. (2010). Salivary glands - "an unisex organ"? Oral Dis. 16, 577-585. doi: 10.1111/j.1601-0825.2010.01669.x
34. La Placa, M., Vitone, F., Bianchi, T., Vincenzi, C., Gibellini, D., Re, M. C., et al. (2004). Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? J. Invest. Dermatol. 123, 407-409. doi: 10.1111/j.0022-202X.2004.23216.x
35. Le Dantec, C., Varin, M. M., Brooks, W. H., Pers, J. O., Youinou, P., and Renaudineau, Y. (2012). Epigenetics and Sjögren's syndrome. Curr. Pharm. Biotechnol. 13, 2046-2053. doi: 10.2174/138920112802273326
36. Lee, B. H., Gauna, A. E., Perez, G., Park, Y. J., Pauley, K. M., Kawai, T., et al. (2013). Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 trafficking. PLoS ONE 8:e53113. doi: 10.1371/journal.pone.0053113
37. Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Rasmussen, A., Grundahl, K. M., et al. (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat. Genet. 45, 1284-1292. doi: 10.1038/ng.2792
38. Lessing, D., Anguera, M. C., and Lee, J. T. (2013). X chromosome inactivation and epigenetic responses to cellular reprogramming. Annu. Rev. Genomics Hum. Genet. 14, 85-110. doi: 10.1146/annurev-genom-091212-153530
39. Li, X., Qian, L., Wang, G., Zhang, H., Wang, X., Chen, K., et al. (2007). T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. J. Rheumatol. 34, 2438-2445.
40. Liu, A., and La Cava, A. (2013). Epigenetic dysregulation in systemic lupus erythematosus. Autoimmunity doi: 10.3109/08916934.2013.844794 [Epub ahead of print].
41. Lu, Q., Renaudineau, Y., Cha, S., Ilei, G., Brooks, W. H., Selmi, C., et al. (2010). Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun. Rev. 9, 627-630. doi: 10.1016/j.autrev.2010.05.011
42. Lu, Q., Wu, A., Tesmer, L., Ray, D., Yousif, N., and Richardson, B. (2007). Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179, 6352-6358.
43. Mavragani, C. P., and Moutsopoulos, H. M. (2010). The geoepidemiology of Sjögren's syndrome. Autoimmun. Rev. 9, A305-A310. doi: 10.1016/j.autrev.2009.11.004
44. Mavragani, C. P., and Moutsopoulos, H. M. (2013). Sjögren's syndrome. Annu. Rev. Pathol. 9, 273-285 doi: 10.1146/annurev-pathol-012513-104728
45. Mazari, L., Ouarzane, M., and Zouali, M. (2007). Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl. Acad. Sci. U.S.A. 104, 6317-6322. doi: 10.1073/pnas.0610434104
46. Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P., and Gilkeson, G. S. (2003). Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539-552. doi: 10.1172/JCI16153
47. Motegi, K., Azuma, M., Tamatani, T., Ashida, Y., and Sato, M. (2005). Expression of aquaporin-5 in and fluid secretion from immortalized human salivary gland ductal cells by treatment with 5-aza-2'-deoxycytidine: a possibility for improvement of xerostomia in patients with Sjögren's syndrome. Lab. Invest. 85, 342-353. doi: 10.1038/labinvest.3700234
48. Moyes, D. L., Martin, A., Sawcer, S., Temperton, N., Worthington, J., Griffiths, D. J., et al. (2005). The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86, 337-341. doi: 10.1016/j.ygeno.2005.06.004
49. Murovska, M., Lejniece, S., Kozireva, S., Koulikovska, M., Yin, H., and Blomberg, J. (2000). Human retrovirus 5 sequences in peripheral blood cells of patients with B-cell non-Hodgkin's lymphoma. Int. J. Cancer 85, 762-770. doi: 10.1002/(SICI)1097-0215(20000315)85:6<762::AID-IJC4>3.0.CO;2-Z
50. Ozcelik, T. (2008). X chromosome inactivation and female predisposition to autoimmunity. Clin. Rev. Allergy Immunol. 34, 348-351. doi: 10.1007/s12016-007-8051-0
51. Pauley, K. M., Cha, S., and Chan, E. K. (2009). microRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 32, 189-194. doi: 10.1016/j.jaut.2009.02.012
52. Pauley, K. M., Stewart, C. M., Gauna, A. E., Dupre, L. C., Kuklani, R., Chan, A. L., et al. (2011). Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur. J. Immunol. 41, 2029-2039. doi: 10.1002/eji.201040757
53. Quddus, J., Johnson, K. J., Gavalchin, J., Amento, E. P., Chrisp, C. E., Yung, R. L., et al. (1993). Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92, 38-53. doi: 10.1172/JCI116576
54. Reilly, C. M., Mishra, N., Miller, J. M., Joshi, D., Ruiz, P., Richon, V. M., et al. (2004). Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J. Immunol. 173, 4171-4178.
55. Renaudineau, Y. (2010). The revolution of epigenetics in the field of autoimmunity. Clin. Rev. Allergy Immunol. 39, 1-2. doi: 10.1007/s12016-009-8171-9
56. Renaudineau, Y., Hillion, S., Saraux, A., Mageed, R. A., and Youinou, P. (2005a). An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 106, 2781-2789. doi: 10.1182/blood-2005-02-0597
57. Renaudineau, Y., Vallet, S., Le Dantec, C., Hillion, S., Saraux, A., and Youinou, P. (2005b). Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun. 6, 663-671. doi: 10.1038/sj.gene.6364253
58. Ross, M. T., Grafham, D. V., Coffey, A. J., Scherer, S., Mclay, K., Muzny, D., et al. (2005). The DNA sequence of the human X chromosome. Nature 434, 325-337. doi: 10.1038/nature03440
59. Sarigul, M., Yazisiz, V., Bassorgun, C. I., Ulker, M., Avci, A. B., Erbasan, F., et al. (2010). The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjögren's syndrome. Lupus 19, 138-145. doi: 10.1177/0961203309348234
60. Sharma, R., Deshmukh, U. S., Zheng, L., Fu, S. M., and Ju, S. T. (2009). X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J. Immunol. 183, 3212-3218. doi: 10.4049/jimmunol.0804355
61. Talal, N., Dauphinee, M. J., Dang, H., Alexander, S. S., Hart, D. J., and Garry, R. F. (1990). Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 33, 774-781. doi: 10.1002/art.1780330603
62. Tandon, M., Gallo, A., Jang, S. I., Illei, G. G., and Alevizos, I. (2012). Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome. Oral Dis. 18, 127-131. doi: 10.1111/j.1601-0825.2011.01849.x
63. Taylor, J. A. (1968). Procainamide toxicity. Lancet 1, 978. doi: 10.1016/S0140-6736(68)90929-X
64. Thabet, Y., Canas, F., Ghedira, I., Youinou, P., Mageed, R. A., and Renaudineau, Y. (2012). Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link? J. Autoimmun. 39, 154-160. doi: 10.1016/j.jaut.2012.05.015
65. Thabet, Y., Le Dantec, C., Ghedira, I., Devauchelle, V., Cornec, D., Pers, J. O., et al. (2013). Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells. J. Autoimmun. 41, 175-181. doi: 10.1016/j.jaut.2013.02.002
66. Tobon, G. J., Renaudineau, Y., Hillion, S., Cornec, D., Devauchelle-Pensec, V., Youinou, P., et al. (2010). The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome. Arthritis Rheum. 62, 3447-3456. doi: 10.1002/art.27611
67. Tobon, G. J., Saraux, A., Gottenberg, J. E., Quartuccio, L., Fabris, M., Seror, R., et al. (2013). Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. Arthritis Rheum. 65, 3218-3227. doi: 10.1002/art.38129
68. Toso, A., Aluffi, P., Capello, D., Conconi, A., Gaidano, G., and Pia, F. (2009). Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands. Head Neck 31, 1181-1187. doi: 10.1002/hed.21087
69. Tugnet, N., Rylance, P., Roden, D., Trela, M., and Nelson, P. (2013). Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? Open Rheumatol. J. 7, 13-21. doi: 10.2174/1874312901307010013
70. van Bavel, C. C., Dieker, J. W., Kroeze, Y., Tamboer, W. P., Voll, R., Muller, S., et al. (2011). Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 70, 201-207. doi: 10.1136/ard.2010.129320
71. Voulgarelis, M., Dafni, U. G., Isenberg, D. A., and Moutsopoulos, H. M. (1999). Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum. 42, 1765-1772. doi: 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V
72. Yamamura, Y., Aota, K., Yamanoi, T., Kani, K., Takano, H., Momota, Y., et al. (2012). DNA demethylating agent decitabine increases AQP5 expression and restores salivary function. J. Dent. Res. 91, 612-617. doi: 10.1177/0022034512446343
73. Yamano, S., Renard, J. N., Mizuno, F., Narita, Y., Uchida, Y., Higashiyama, H., et al. (1997). Retrovirus in salivary glands from patients with Sjögren's syndrome. J. Clin. Pathol. 50, 223-230. doi: 10.1136/jcp.50.3.223
74. Yin, H., Zhao, M., Wu, X., Gao, F., Luo, Y., Ma, L., et al. (2010). Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome. J. Dermatol. Sci. 59, 198-203. doi: 10.1016/j.jdermsci.2010.06.011
75. Zare-Shahabadi, A., Renaudineau, Y., and Rezaei, N. (2013). MicroRNAs and multiple sclerosis: from physiopathology toward therapy. Expert Opin. Ther. Targets 17, 1497-1507. doi: 10.1517/14728222.2013.838219
76. Zhou, Y., Qiu, X., Luo, Y., Yuan, J., Li, Y., Zhong, Q., et al. (2011). Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus 20, 1365-1371. doi: 10.1177/0961203311413412
77. Zilahi, E., Tarr, T., Papp, G., Griger, Z., Sipka, S., and Zeher, M. (2012). Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren' syndrome. Immunol. Lett. 141, 165-168. doi: 10.1016/j.imlet.2011.09.006